A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition:   AIDS-related Kaposi's SarcomaInterventions:   Drug: abacavir/3TC/zidovudine;   Drug: abacavir /3TC plus ritonavir boosted lopinavirSponsors:   Parirenyatwa Hospital;   University of Colorado, Denver;   GlaxoSmithKline;   AbbottCompleted - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials